Opzelura 1.5% Cream (Ruxolitinib / Rutinib) – Advanced JAK Inhibitor for Vitiligo & Eczema
Opzelura 1.5% Cream, containing Ruxolitinib, is a breakthrough topical treatment designed for inflammatory and autoimmune skin conditions such as vitiligo and atopic dermatitis (eczema). As a potent JAK1/JAK2 inhibitor, it targets the underlying immune pathways that trigger inflammation, pigment loss, itching, and skin irritation.
This 30 gm cream is fast-absorbing, non-greasy, and suitable for daily use. Dermatologists often recommend Opzelura for patients who need a steroid-free option for long-term management.
⭐ How Opzelura (Ruxolitinib) Works
Conditions like vitiligo and eczema result from overactive immune signaling.
Ruxolitinib works by:
-
Blocking abnormal JAK1/JAK2 activity
-
Reducing skin inflammation
-
Decreasing itching, redness, and irritation
-
Supporting repigmentation in vitiligo
-
Helping restore a healthy skin barrier
This targeted mechanism helps improve both symptoms and visible skin appearance over time.
⭐ Key Benefits
-
Effective for vitiligo repigmentation
-
Reduces itching, redness, and swelling
-
Steroid-free option for sensitive skin
-
Suitable for chronic or recurrent eczema
-
Smooth, non-oily, comfortable cream texture
-
Safe for long-term use under medical guidance
⭐ How to Use
-
Apply a thin layer 1–2 times daily on affected skin
-
Avoid eyes, mouth, and broken skin
-
Use consistently for best long-term results
-
Follow dermatologist instructions for sensitive areas
⭐ Side Effects
Usually mild and temporary:
-
Light burning or stinging
-
Mild redness
-
Temporary irritation
If irritation persists, consult a healthcare provider.
⭐ Storage Instructions
-
Store below 25°C
-
Keep away from direct light and moisture
-
Close the tube tightly after use
-
Keep out of children’s reach
Frequently Asked Questions (FAQs)
1. Is Ruxolitinib 1.5% cream safe for children?
Yes. It may be prescribed for children 12 years and older, as long as they are under proper medical supervision.
2. Can this cream be applied on the face?
Yes, it can be used on facial areas, but avoid highly sensitive regions such as the eyes, eyelids, and lips. Apply only a thin, even layer as directed by a dermatologist.
3. When will I start seeing results?
Many users begin to see improvements within 2–4 weeks, while full benefits typically develop over several months of consistent use.
4. Are there any long-term side effects?
Long-term application is generally considered safe when monitored by a healthcare provider. Regular check-ups ensure the treatment remains effective and well tolerated.
5. Can I use this cream alongside other topical treatments?
Use additional creams only if recommended by a dermatologist. This helps prevent irritation or unwanted interactions between products.
6. Do I need a prescription to buy Ruxolitinib 1.5% cream?
Yes. Ruxolitinib 1.5% cream (Opzelura / Rutinib) is a prescription-only medication and should be used under medical guidance.
